E. L. White

High-throughput screening for inhibitors of Mycobacterium tuberculosis H37Rv.

Lynn Rasmussen, E Lucile White, Subramaniam Ananthan, 2009, Tuberculosis.

Identification of a Novel HIV-1 Inhibitor Targeting Vif-dependent Degradation of Human APOBEC3G Protein*

Erez Pery, R. Ptak, N. M. Nebane, 2015, The Journal of Biological Chemistry.

A cell-based luminescence assay is effective for high-throughput screening of potential influenza antivirals.

C. Jonsson, D. Noah, J. Noah, 2007, Antiviral research.

High throughput screening of a library based on kinase inhibitor scaffolds against Mycobacterium tuberculosis H37Rv.

Lynn Rasmussen, E Lucile White, Wei Zhang, 2012, Tuberculosis.

Combining Computational Methods for Hit to Lead Optimization in Mycobacterium Tuberculosis Drug Discovery

Sean Ekins, Joel S. Freundlich, Robert C. Reynolds, 2013, Pharmaceutical Research.

Antituberculosis activity of the molecular libraries screening center network library.

Lynn Rasmussen, E Lucile White, Wei Zhang, 2009, Tuberculosis.

Discovery of Clinically Approved Agents That Promote Suppression of Cystic Fibrosis Transmembrane Conductance Regulator Nonsense Mutations.

D. Bedwell, K. Keeling, S. Rowe, 2016, American journal of respiratory and critical care medicine.

A High-Throughput Screening Assay for Inhibitors of Bacterial Motility Identifies a Novel Inhibitor of the Na+-Driven Flagellar Motor and Virulence Gene Expression in Vibrio cholerae

Anisia J. Silva, J. Benitez, E. White, 2011, Antimicrobial Agents and Chemotherapy.

Development and Validation of a High-Throughput Screen for Inhibitors of SARS CoV and Its Application in Screening of a 100,000-Compound Library

E Lucile White, Subramaniam Ananthan, C. Jonsson, 2007, SLAS Discovery.